Aktienkurs
9.09
Täglich Wechseln
-0.02 -0.22%
Monatlich
-9.37%
Jährlich
-14.25%
Q2 Prognose
8.82




Fremdkapital Veränderung Datum
Avita Medical AUD 42.24M 1.25M 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Mesoblast USD 66.02M 1.72M 2025-12
Pacific Edge NZD 551K 637K 2025-12
Paradigm Biopharmaceuticals AUD 436.81K 336.81K 2025-12
PYC Therapeutics AUD 436.93K 188.06K 2025-12
Telix Pharmaceuticals AUD 448.45M 76.97M 2025-12